DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» DYRK1A
DYRK1A
Aberrant Methylation Underlies Insulin Gene Expression in Human Insulinoma
Correction of Cognitive Deficits in Mouse Models Of
The Mutational Landscape of Myeloid Leukaemia in Down Syndrome
Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases Andrea I
DYRK1A Binds to an Evolutionarily Conserved WD40-Repeat Title Protein WDR68 and Induces Its Nuclear Translocation
DYRK1A Inhibition and Cognitive Rescue in a Down Syndrome Mouse
Small Molecule Inhibitors of DYRK1A Identified by Computational And
Increased Dosage of the Chromosome 21 Ortholog Dyrk1a Promotes Megakaryoblastic Leukemia in a Murine Model of Down Syndrome
DYRK1A, Active Recombinant Full-Length Protein Expressed in E.Coli
Trisomy 21-Associated Defects in Human Primitive Hematopoiesis Revealed Through Induced Pluripotent Stem Cells
DYRK1A: the Double-Edged Kinase As a Protagonist in Cell Growth and Tumorigenesis
Regulation of the Stability of the Protein Kinase DYRK1A: Establishing Connections with the Wnt Signaling Pathway
Research Article Identification of Plant Homologues of Dual Specificity Yak1-Related Kinases
Case Report of Novel DYRK1A Mutations in 2 Individuals with Syndromic Intellectual Disability and a Review of the Literature Stephanie M
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases
1 Trisomy 21 Consistently Activates the Interferon Response Kelly D
High-Throughput Single-Cell Functional Elucidation of Neurodevelopmental Disease–Associated Genes Reveals Convergent Mechanisms Altering Neuronal Differentiation
DYRK1A Targets Pol II
Top View
Acute Myeloid Leukemia in Down Syndrome
DYRK1A Regulates Hap1–Dcaf7/WDR68 Binding with Implication for Delayed Growth in Down Syndrome
Autismnext Positive Sample Report
Development of a Novel Selective Inhibitor of the Down Syndrome-Related Kinase Dyrk1a
DCAF7/WDR68 Is Required for Normal Levels of DYRK1A and DYRK1B
Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update
Down Syndrome and Leukemia: Insights Into Leukemogenesis and Translational Targets
Inhibition of DYRK1A Stimulates Human Β-Cell Proliferation
Dyrk1a Truncation Mutants Impair Neuronal Dendritic and Spine Growth and Interfere with Postnatal Cortical Development
Integrative Approach to Interpret DYRK1A Variants, Leading to a Frequent 2 Neurodevelopmental Disorder
DYRK1A, Related Kinases and Human Disease
The Parkinson's Disease GWAS Locus Browser
Indole-3-Carbonitriles As DYRK1A Inhibitors by Fragment-Based Drug Design
Annulated Halogen-Substituted Indoles As Potential DYRK1A Inhibitors
A Network-Based Approach to Uncover Microrna-Mediated Disease Comorbidities and Potential Pathobiological Implications
Down Syndrome Phenotype in a Boy with A
DYRK1A Inhibitors
High-Throughput Single-Cell Functional Elucidation of Neurodevelopmental Disease-Associated Genes Reveals Convergent Mechanisms Altering Neuronal Differentiation